- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
KIMIA BIOSCIENCES announced the outcome of its Board meeting. The Board approved the financial results for the quarter ended June 30, 2025. Key decisions include the approval to raise an unsecured loan of 2 Cr at an 8% annual interest rate, which will impact the company's financial flexibility. Additionally, the Board noted and discussed a warning letter from BSE Limited. A significant management change was the appointment of Mr. Pradip Kumar Sharma as the new Chief Financial Officer, crucial for the company's financial oversight.